Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A‐mediated regulation of proliferation and cytolytic activity
- 1 June 1996
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 26 (6) , 1266-1272
- https://doi.org/10.1002/eji.1830260613
Abstract
In this study, we show that NKRP1A is expressed and functions on a subset of immature human thymocytes. We took advantage of the monoclonal antibody (mAb) 191B8 that was obtained by immunizing mice with cultured human thymocytes characterized by an immature surface phenotype [CD2− CD3− CD4− CD8− stem cell factor receptor (SCFR)+] and expressing cytoplasmic CD3ϵ chain. The 191B8 antibody homogeneously reacted with the immunizing population but not with most unfractionated thymocytes. It stained a minor population of resting immature thymocytes co-expressing CD34, SCFR, or both. Following culture of the CD34+ or CD34− fractions of CD2− CD3− CD4− CD8− purified immature thymocytes with recombinant interleukin-2 (rIL-2), the 191B8-defined antigen was expressed on virtually all cells even when 191B8+ cells were removed from the starting population. On the other hand, no 191B8+ cells were detected in fresh or cultured thymocytes expressing a more mature phenotype. Biochemical analysis of 191B8 mAb-reactive molecules revealed, under non-reducing conditions, two bands displaying apparent molecular masses of 80 and 44 kDa and a single band of 44 kDa under reducing conditions. Digestion with proteases indicated that the 80-kDa form represented a homodimeric form of two 44-kDa molecules, while deglycosylation with N-glycanase suggested the existence of four N-glycosylation sites. Transfection of COS7 or NIH3T3 cells with hNKRP1A cDNA showed that the 191B8 mAb recognized NKRP1A as shown by both immunofluorescence analysis and immu-noprecipitation experiments. Functional studies showed that the 191B8/NKRP1A molecule mediated strong inhibition of the cytolytic activity of culturd CD2− CD3− immature thymocytes against a panel of tumor target cells. More importantly, 191B8 mAb induced proliferation of CD2− CD3− fresh thymocytes which was not increased by rIL-2. Thus, we propose that NKRP1A molecules, which are expressed in highly immature thymocytes, may play a regulatory role in their growth and function.Keywords
This publication has 41 references indexed in Scilit:
- Mouse NK1.1+ T cells: a new family of T cellsImmunology Today, 1996
- Development of human NK cells from the immature cell precursorsSeminars in Immunology, 1995
- p40, a novel surface molecule involved in the regulation of the non‐major histocompatibility complex‐restricted cytolytic activity in humansEuropean Journal of Immunology, 1995
- Early stages in human and mouse T-cell developmentCurrent Opinion in Immunology, 1994
- The Ly-49 and NKR-P1 Gene Families Encoding Lectin-Like Receptors on Natural Killer Cells: The NK Gene ComplexAnnual Review of Immunology, 1993
- NK1.1+ CD4+ CD8‐ thymocytes with specific lymphokine secretionEuropean Journal of Immunology, 1993
- CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.The Journal of Experimental Medicine, 1991
- NKR-P1, a Signal Transduction Molecule on Natural Killer CellsScience, 1990
- Ontogeny of T-cell precursors: a model for the initial stages of human T-cell developmentImmunology Today, 1989
- Involvement of the interleukin 2 pathway in the rearrangement and expression of both alpha/beta and gamma/delta T cell receptor genes in human T cell precursors.The Journal of Experimental Medicine, 1988